Related Experiment Video
Updated: Aug 8, 2026

13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
[Western blotting analysis of cryoglobulins associated with chronic hepatitis C]
Insights
A prospective study found monoclonal components in 33% of mixed cryoglobulinemia (MC) patients with hepatitis C virus (HCV) infection. These components were predominantly IgM, highlighting a significant association between HCV, MC, and monoclonal gammopathies.
Area of Science:
- Immunology
- Hepatology
- Hematology
Context:
- Mixed cryoglobulinemia (MC) is a systemic vasculitis often associated with chronic infections, particularly hepatitis C virus (HCV).
- The presence and characteristics of monoclonal components in MC-HCV patients require further elucidation.
- Understanding these associations is crucial for diagnosis and management.
Purpose:
- To investigate the prevalence and characteristics of monoclonal components in patients with mixed cryoglobulinemia (MC) associated with hepatitis C virus (HCV) infection.
- To determine the immunoglobulin type and light chain distribution of monoclonal components.
- To assess the presence of HCV markers in MC patients with and without monoclonal components.
Summary:
- A prospective study identified monoclonal components in 29 out of 89 (33%) patients with MC-HCV.
- The predominant immunoglobulin was IgM (87%), with a Kappa/Lambda ratio of 1.8.
- Hepatitis C virus RNA and anti-HCV antibodies were detected in MC patients irrespective of monoclonal component presence.
Impact:
- This study enhances understanding of the immunopathogenesis of MC-HCV.
- Findings may guide diagnostic strategies and risk stratification for MC-HCV patients.
- Highlights the importance of screening for monoclonal gammopathies in HCV-related cryoglobulinemia.
Abstract:
In a prospective study, a monoclonal component was found in 29/89 (33%) of mixed cryoglobulinemia (MC) associated with hepatitis C virus (HCV) infection, with a IgM in 87% of cases and a Kappa/Lambda ratio at 1.8. HCV RNA anti-HCV antibodies were demonstrated in both MC with and without monoclonal component.

